Solara Active Pharma Dispatches KYC and Nomination Reminders to Physical Shareholders
Solara Active Pharma Sciences Ltd 路 Others (Uncategorized) 路 27 Sept 2026, 4:27 am
Solara Active Pharma Dispatches KYC and Nomination Reminders to Physical Shareholders Solara Active Pharma Sciences completed the dispatch of reminder letters on 26th Sep'26 to shareholders holding shares in physical mode, pursuant to SEBI's Master Circular. Physical shareholders are required to furnish their PAN, KYC, bank details, specimen signatures, and nominations to the RTA, Cameo Corporate Services. The RTA will freeze processing of service requests and complaints until these details are registered. Additionally, dividends for physical shareholdings will only be processed electronically.
Original exchange filing (PDF)
More announcements from Solara Active Pharma Sciences Ltd
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 路 23 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding the dispatch of Final Reminder -cum-Forfeiture Notice for the payment of outstanding call money to the holders .... 路 18 Oct 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 路 17 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 路 17 Oct 2026
- Solara Active Pharma Sciences Limited has informed the exchange about the Statement of Deviation/Variation in utilization of funds raised though Rights issue for the quarter ended September 30 2026 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding grant of 470000 options under Solara Employee Stock Option Plan 2024 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding a Press Release dated October 16, 2026, titled "Solara''s Q2 FY 27 revenue grows 33% to INR 4,178 Mn and EBITDA .... 路 16 Oct 2026
- Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 8,300 Equity shares pursuant to exercise of ESOP options. 路 16 Oct 2026
